Medical management of intestinal obstruction in terminal care

Canadian Family Physician

Volumn 43, Issue FEB., 1997, Pages 259-265

  Frank, Christopher ^a  

^a St Mary's of the Lake Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLIZINE; DEXAMETHASONE; DIMENHYDRINATE; DOMPERIDONE; HALOPERIDOL; LOPERAMIDE; METOCLOPRAMIDE; MORPHINE; OCTREOTIDE; PHENOTHIAZINE DERIVATIVE; PROCHLORPERAZINE; SCOPOLAMINE BUTYL BROMIDE; SOMATOSTATIN DERIVATIVE; TRANQUILIZER;

ADVANCED CANCER; ANALGESIA; ARTICLE; DATA ANALYSIS; GASTROSTOMY; HOME CARE; HUMAN; HYDRATION; INTESTINE OBSTRUCTION; NAUSEA; SYMPTOMATOLOGY; TERMINAL CARE; VOMITING;

ANALGESICS, OPIOID; ANTIEMETICS; FLUID THERAPY; GASTROSTOMY; HUMANS; INTESTINAL OBSTRUCTION; INTUBATION, GASTROINTESTINAL; NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; RESEARCH DESIGN; TERMINAL CARE;

EID: 0030937277     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Beattie GJ, Leonard R, Smyth JF. Bowel obstruction in ovarian carcinoma: a retrospective study and review of the literature. Palliat Med 1989;3:275-80.
2. Kyllonen LEJ. Obstruction and perforation complicating colorectal carcinoma. Acta Chir Scand 1987;153:607-14.
3. Baines M, Oliver DJ, Carter RL Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet 1985;2:990-3.
4. Fernandes JR, Seymour RJ, Suissa S. Bowel obstruction in patients with ovarian cancer a search for prognostic factors. Am J Obstet Gynecol 1988;158:244-8.
5. Lund B, Hansen M, Lundvall F, Nielsen NC, Sorensen BL, Hansen HH. Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy. Surg Gynecol Obstet 1989;169:213-8.
6. Gallick HL, Weaver DW, Sachs RJ, Bouwman DL Intestinal obstruction in cancer patients: an assessment of risk factors and outcome. Am Surg 1986;52:434-7.
7. Annest LS, Jolly PC. The results of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis. Am Surg 1979;45:718-21.
8. Larson JE, Podczaski ES, Manetta A, Whitney CW, Mortel R. Bowel obstruction in patients with ovarian carcinoma: analysis of prognostic factors. Gynecol Oncol 1989;35:61-5.
9. Ventafridda V, Ripamonti C, Caraceni A, Spoldi E, Messina L, De Conno F. The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 1990; 76:389-93.
10. Fainsinger RL, Spachynski K, Hanson J, Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction. J Pain Symptom Manage 1994;9:12-8.
11. Reid DB. Palliative management of bowel obstruction [letter]. Med J Aust 1988;148:54.
12. Ripamonti C. Management of bowel obstruction in advanced cancer patients. J Pain Symptom Manage 1994;3:193-200.
13. Farr WC. The use of corticosteroids for symptom management in terminally ill patients. Am J Hospice Palliat Care 1990;7(1):41-6.
14. Khoo D, Hall E, Motson R, Riley J, Denman K, Waxman J. Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer 1994;30A(1):28-30.
15. Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MY. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 1993;7:42-6.
16. Aabo K, Pederson H, Bach F, Knudson J. Surgical management of intestinal obstruction in the late course of malignant disease. Acta Chir Scand 1984;150:173-6.
17. Turnbull AD, Guerra J, Starnes HF. Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic or biliary origin. J Clin Oncol 1989;7:381-6.
18. Chan A, Woodruff RK. Intestinal obstruction in patients with widespread intra-abdominal malignancy. J Pain Symptom Manage 1992;7:339-42.
19. Soo KC, Davidson T, Parker M, Paterson I, Paterson A. Intestinal obstruction in patient with gynecological malignancies. Ann Acad Med Singapore 1988;17:72-5.
20. Walsh HPJ, Schofield PF. Is laparotomy for small bowel obstruction justified in patients with previously treated malignancy? Br J Surg 1984;71:933-5.
21. Aranha GV, Folk FA, Greenlee HB. Surgical palliation of small bowel obstruction due to metastatic carcinoma. Am Surg 1981;47:99-102.
22. Mercadante S. The role of octreotide in palliative care. J Pain Symptom Manage 1994;9:406-11.
23. Rousseau P. Antiemetic therapy in adults with terminal disease: abrief review. Am J Hospice Palliat Care 1995; 12(1):13-8.
24. Arnold R, Lankisch PG. Somatostatin and gastrointestinal tract. Clin Gastroenterol 1980;9:733-53.
25. Dharmsathophorn K, Gorelock FS, Sherwin RS, Cataland S, Dobbins JW. Somatostatin decreases diarrhea in patients with short bowel syndrome. J Clin Gastroenterol 1982;4:521-4.
26. Nubiola-Calonge P, Sancho J, Segura M, Badia JM, Gil MJ, Sitges-Serra A. Blind evaluation of the effect of octreotide (SMS 201-995), a Somatostatin analogue, on small-bowel fistula output. Lancet 1987;2:6724.
27. Mercadante S. Treatment of diarrhea due to enterocolic fistula with octreotide in a terminal cancer patient. Palliat Med 1992;6:257-9.
28. Pictus D, Marx MV, Weyman PJ. Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement. Am J Radiol 1988;150:295-7.
29. Gemlo B, Rayne AA, Lewis B. Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy. Am J Surg 1986;152:1004.